PEAK6 Investments’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-15,856
Closed -$154K – 4746
2022
Q3
$154K Buy
+15,856
New +$210K ﹤0.01% 3835
2021
Q3
– Sell
-4,389
Closed -$239K – 5385
2021
Q2
$244K Buy
4,389
+161
+4% +$8.58K ﹤0.01% 3863
2021
Q1
$198K Buy
+4,228
New +$205K ﹤0.01% 3931

Other funds holding HCAT

PEAK6 Investments's HCAT Position: Q4 2022 in Review

PEAK6 Investments sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 15,856 shares — an estimated $154K sold.

PEAK6 Investments first reported a position in HCAT in Q1 2021 and held it in 3 quarters. The position peaked at $244K in Q2 2021. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • PEAK6 Investments reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • PEAK6 Investments sold 15,856 Health Catalyst shares in Q4 2022, an estimated $154K.
  • PEAK6 Investments first reported a position in Health Catalyst in Q1 2021 and held it in 3 quarters.
  • PEAK6 Investments's Health Catalyst position peaked at $244K in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.